Market Cap

Immunocore Holdings plc Market Capitalization:

$1.65 Billion

USD as of July 1, 2025

business Immunocore Holdings plc Company Profile

Immunocore Holdings plc Main Stock Listing

NASDAQ: IMCR

Market Capitalization History of Immunocore Holdings plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $309.91 B
Vertex Pharmaceuticals Incorporated $117.36 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $59.14 B
Marinomed Biotech AG $58.56 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Immunocore Holdings plc market cap

Date Market Cap YoY Change
Jan. 1, 2025 $1.42 B -56.93%
Jan. 1, 2024 $3.29 B 26.25%
Jan. 1, 2023 $2.61 B 153.19%
Jan. 1, 2022 $1.03 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Immunocore Holdings plc Categories

United Kingdom languages Healthcare languages Biotechnology
United Kingdom Healthcare United Kingdom Biotechnology

Stocks & Indices

Immunocore Holdings plc has the following listings and related stock indices.


Stock: NASDAQ: IMCR

Stock: FSX: 6YG

Stock: Munich: 6YG

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.